A retrospective multicenter study assessing the bleeding risk of the novel anticoagulants after an exploratory ingestion in children 6 years or younger
Latest Information Update: 15 Feb 2021
At a glance
- Drugs Apixaban (Primary) ; Clopidogrel (Primary) ; Dabigatran etexilate (Primary) ; Edoxaban (Primary) ; Prasugrel (Primary) ; Rivaroxaban (Primary) ; Ticagrelor (Primary)
- Indications Thrombosis
- Focus Adverse reactions
- 15 Feb 2021 New trial record